{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:43Z","timestamp":1707524923398},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,3]]},"DOI":"10.7759\/cureus.35735","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T19:28:10Z","timestamp":1677871690000},"source":"Crossref","is-referenced-by-count":1,"title":["Upgrade Rate of Ductal Carcinoma In Situ to Invasive Carcinoma and the Clinicopathological Factors Predicting the Upgrade Following a Mastectomy: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Zaid","family":"Al-Ishaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Hajiesmaeili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsanur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muskaan","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tapan","family":"Sircar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-021-01225-0","article-title":"Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study","volume":"28","author":"Tanaka K","year":"2021","unstructured":"Tanaka K, Masuda N, Hayashi N, et al.. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study. Breast Cancer. 2021, 28:896-903. 10.1007\/s12282-021-01225-0","journal-title":"Breast Cancer"},{"key":"ref2","unstructured":"Cancer Research UK. Breast cancer stages, types and grades. Ductal carcinoma in situ (DCIS). (2022). Accessed. January 25, 2023: https:\/\/www.cancerresearchuk.org\/about-cancer\/breast-cancer\/stages-types-grades\/types\/ductal-carcinoma-in-situ-dcis."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm LJ","year":"2017","unstructured":"Grimm LJ, Ryser MD, Partridge AH, Thompson AM, Thomas JS, Wesseling J, Hwang ES. Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials. Ann Surg Oncol. 2017, 24:3534-40. 10.1245\/s10434-017-6018-9","journal-title":"Ann Surg Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6417-3","article-title":"Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy","volume":"19","author":"Lee KH","year":"2019","unstructured":"Lee KH, Han JW, Kim EY, Yun JS, Park YL, Park CH. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy. BMC Cancer. 2019, 19:1201. 10.1186\/s12885-019-6417-3","journal-title":"BMC Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2014.01.010","article-title":"Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer","volume":"83","author":"Park AY","year":"2014","unstructured":"Park AY, Gweon HM, Son EJ, Yoo M, Kim JA, Youk JH. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. Eur J Radiol. 2014, 83:654-9. 10.1016\/j.ejrad.2014.01.010","journal-title":"Eur J Radiol"},{"key":"ref6","unstructured":"National Institute of for Health and Care Excellence. Early and locally advanced breast cancer. diagnosis and management. NICE guideline [NG101]. (2018). Accessed: January 23, 2023: https:\/\/www.nice.org.uk\/guidance\/ng101."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4476-5","article-title":"The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the Cinnamome prospective multicenter study","volume":"22","author":"Tunon-de-Lara C","year":"2015","unstructured":"Tunon-de-Lara C, Chauvet MP, Baranzelli MC, et al.. The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the Cinnamome prospective multicenter study. Ann Surg Oncol. 2015, 22:3853-60. 10.1245\/s10434-015-4476-5","journal-title":"Ann Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-0871-7","article-title":"Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy","volume":"25","author":"Watanabe Y","year":"2018","unstructured":"Watanabe Y, Anan K, Saimura M, et al.. Upstaging to invasive ductal carcinoma after mastectomy for ductal carcinoma in situ: predictive factors and role of sentinel lymph node biopsy. Breast Cancer. 2018, 25:663-70. 10.1007\/s12282-018-0871-7","journal-title":"Breast Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13737","article-title":"Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS)","volume":"26","author":"Price A","year":"2020","unstructured":"Price A, Schnabel F, Chun J, et al.. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS). Breast J. 2020, 26:931-6. 10.1111\/tbj.13737","journal-title":"Breast J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan ME","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology. 2011, 260:119-28. 10.1148\/radiol.11102368","journal-title":"Radiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S314447","article-title":"Ductal carcinoma in situ: underestimation of percutaneous biopsy and positivity of sentinel lymph node biopsy in a Brazilian public hospital","volume":"13","author":"S\u00e1 RD","year":"2021","unstructured":"S\u00e1 RD, Logullo AF, Elias S, Facina G, Sanvido VM, Naz\u00e1rio AC. Ductal carcinoma in situ: underestimation of percutaneous biopsy and positivity of sentinel lymph node biopsy in a Brazilian public hospital. Breast Cancer (Dove Med Press). 2021, 13:409-17. 10.2147\/BCTT.S314447","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2012.06.012","article-title":"Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision","volume":"21","author":"Kim J","year":"2012","unstructured":"Kim J, Han W, Lee JW, et al.. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast. 2012, 21:641-5. 10.1016\/j.breast.2012.06.012","journal-title":"Breast"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22435","article-title":"Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates","volume":"109","author":"Houssami N","year":"2007","unstructured":"Houssami N, Ciatto S, Ellis I, Ambrogetti D. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer. 2007, 109:487-95. 10.1002\/cncr.22435","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zrac022","article-title":"Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis","volume":"6","author":"Davey MG","year":"2022","unstructured":"Davey MG, O'Flaherty C, Cleere EF, et al.. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: systematic review and meta-analysis. BJS Open. 2022, 6:zrac022. 10.1093\/bjsopen\/zrac022","journal-title":"BJS Open"},{"key":"ref15","unstructured":"National Comprehensive Cancer Network. Breast Cancer (Version 4.2022). (2022). Accessed. January 25, 2023: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2016.04.019","article-title":"Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in\u00a0situ? A systematic literature review and meta-analysis","volume":"213","author":"El Hage Chehade H","year":"2017","unstructured":"El Hage Chehade H, Headon H, Wazir U, Abtar H, Kasem A, Mokbel K. Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in\u00a0situ? A systematic literature review and meta-analysis. Am J Surg. 2017, 213:171-80. 10.1016\/j.amjsurg.2016.04.019","journal-title":"Am J Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.061457","article-title":"Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?","volume":"62","author":"Doyle B","year":"2009","unstructured":"Doyle B, Al-Mudhaffer M, Kennedy MM, et al.. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?. J Clin Pathol. 2009, 62:534-8. 10.1136\/jcp.2008.061457","journal-title":"J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jum.14722","article-title":"Predictors of invasive breast cancer in patients with ductal carcinoma in situ in ultrasound-guided core needle biopsy","volume":"38","author":"Shin YJ","year":"2019","unstructured":"Shin YJ, Kim SM, Yun B, Jang M, Kim B, Lee SH. Predictors of invasive breast cancer in patients with ductal carcinoma in situ in ultrasound-guided core needle biopsy. J Ultrasound Med. 2019, 38:481-8. 10.1002\/jum.14722","journal-title":"J Ultrasound Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2010.243","article-title":"Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ","volume":"145","author":"Kurniawan ED","year":"2010","unstructured":"Kurniawan ED, Rose A, Mou A, et al.. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ. Arch Surg. 2010, 145:1098-104. 10.1001\/archsurg.2010.243","journal-title":"Arch Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21077","article-title":"Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus","volume":"98","author":"Lee JW","year":"2008","unstructured":"Lee JW, Han W, Ko E, et al.. Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus. J Surg Oncol. 2008, 98:15-20. 10.1002\/jso.21077","journal-title":"J Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2103-9","article-title":"Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy","volume":"21","author":"Cho N","year":"2011","unstructured":"Cho N, Moon WK, Chang JM, Yi A, Koo HR, Park JS, Park IA. Sonoelastographic lesion stiffness: preoperative predictor of the presence of an invasive focus in nonpalpable DCIS diagnosed at US-guided needle biopsy. Eur Radiol. 2011, 21:1618-27. 10.1007\/s00330-011-2103-9","journal-title":"Eur Radiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24037","article-title":"A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast","volume":"112","author":"Kondo T","year":"2015","unstructured":"Kondo T, Hayashi N, Ohde S, et al.. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast. J Surg Oncol. 2015, 112:476-80. 10.1002\/jso.24037","journal-title":"J Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9167-2","article-title":"Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: Analysis of 587 cases","volume":"98","author":"Goyal A","year":"2006","unstructured":"Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: Analysis of 587 cases. Breast Cancer Res Treat. 2006, 98:311-4. 10.1007\/s10549-006-9167-2","journal-title":"Breast Cancer Res Treat"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen TW","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI, et al.. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005, 200:516-26. 10.1016\/j.jamcollsurg.2004.11.012","journal-title":"J Am Coll Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2172","article-title":"Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy","volume":"189","author":"Lee JM","year":"2007","unstructured":"Lee JM, Kaplan JB, Murray MP, Mazur-Grbec M, Tadic T, Stimac D, Liberman L. Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol. 2007, 189:468-74. 10.2214\/AJR.07.2172","journal-title":"AJR Am J Roentgenol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2007.09.005","article-title":"Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent","volume":"17","author":"Santamar\u00eda G","year":"2008","unstructured":"Santamar\u00eda G, Velasco M, Farr\u00fas B, Zan\u00f3n G, Fern\u00e1ndez PL. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent. Breast. 2008, 17:186-94. 10.1016\/j.breast.2007.09.005","journal-title":"Breast"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2013.12.002","article-title":"Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery","volume":"23","author":"Guillot E","year":"2014","unstructured":"Guillot E, Vaysse C, Goetgeluck J, et al.. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery. Breast. 2014, 23:97-103. 10.1016\/j.breast.2013.12.002","journal-title":"Breast"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-017-1197-1","article-title":"Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study","volume":"15","author":"Carin AJ","year":"2017","unstructured":"Carin AJ, Moli\u00e8re S, Gabriele V, Lodi M, Thi\u00e9baut N, Neuberger K, Mathelin C. Relevance of breast MRI in determining the size and focality of invasive breast cancer treated by mastectomy: a prospective study. World J Surg Oncol. 2017, 15:128. 10.1186\/s12957-017-1197-1","journal-title":"World J Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142262-upgrade-rate-of-ductal-carcinoma-in-situ-to-invasive-carcinoma-and-the-clinicopathological-factors-predicting-the-upgrade-following-a-mastectomy-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:06Z","timestamp":1707508446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142262-upgrade-rate-of-ductal-carcinoma-in-situ-to-invasive-carcinoma-and-the-clinicopathological-factors-predicting-the-upgrade-following-a-mastectomy-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.35735","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}